IBC's 4th Annual BioProcess International™ China

[ritap]

Bringing together global leaders to provide you with proven scientific and technical strategies and innovations on:

•Cell Line Engineering, Cell Culture and Media Development
•Analytical Characterization, Comparability and Quality Assessment
•Downstream Processing and Viral Safety
•Single-Use Systems and Multi-Product Facilities
•Biosimilars Development - Regulatory and Market Challenges
Delivering you so much MORE in just 2 days...

•Experts from US and Europe with proven success stories
•Access to international service providers
•Facilitated networking
•Tactical strategies for informed decision making

New This Year! Hear from:
•Pfizer who will explore innovative solutions to streamline cell culture development platform process
•Henlius Biopharmaceuticals who will share their strategy from cell line development to filing IND for a biosimilar in less than 2 years
•Genentech who will take on comparability assessment for clinical development and post-approval CMC changes
•Novartis who will compare HPLC, CE, Mass Spec., NMR and other analytical technologies in the characterization of biological products
•Phage Pharmaceuticals who will detail the design of a multi-product, multi-phases, and multi-users cGMP facility
•Biocon India who will outline their low risk, flexible plant approach using single-use systems
Don't miss this opportunity to witness and partake in China's phenomenal growth! Get insider information and proven strategies to help increase your yield, improve your quality while ensuring efficiency of production and reducing manufacturing cost.


http://www.ibclifesciences.com/BPIChina